Noveome initiates phase 2 clinical trial for allergic conjunctivitis

Noveome Biotherapeutics Inc. announced the initiation of a phase 2 clinical trial of ST266, the company’s novel secretome for treating patients with allergic conjunctivitis, according to a press release.ST266 harnesses paracrine signaling and has been found to help promote cellular homeostasis, modulate inflammation and regenerate damaged cells, according to the company.

Improvements seen with intravitreal infliximab for treatment of uveitis in Behçet’s disease

Intravitreal infliximab for the treatment of refractory posterior uveitis in Behçet’s disease significantly improved logMAR best corrected visual acuity and decreased central foveal thickness, according to a study.Researchers included 20 patients with refractory posterior uveitis in Behçet’s disease and assessed BCVA, vitreous haze, vasculitis, papillopathy and retinitis at baseline and postoperatively at day 1 and weeks 2, 4, 6, 8, 12 and 18. Additionally, flash electroretinogram and OCT were examined at baseline and postoperatively at weeks 4, 12 and 18.

CMS: US health spending reached $3.2 trillion in 2015

In 2015, the national overall and per-capita health expenditures increased by 5.8% and 5%, respectively, reaching $3.2 trillion, or $9,990 per person, according to a study by CMS published in Health Affairs.“Following five consecutive years of historically low growth, from 2009 through 2013, health spending growth accelerated in 2014 (to 5.3%) and 2015 (to 5.8%),” Anne B. Martin, lead researcher from the office of the actuary at CMS, and colleagues wrote. “The faster growth in 2014 and 2015 occurred as the Affordable Care Act (ACA) expanded health insurance coverage for (Read more...)

Femtosecond lasers may lead transition to new practice model

VIENNA — Femtosecond laser-assisted cataract surgery has a high cost, and some say it does not outperform skilled standard phacoemulsification surgery. However, it may lead the transition to a new practice model in which optimized workflow, strategic planning and a team approach can efficiently deal with high-volume surgery, according to Rupert Menapace, MD, moderator of a session on femtosecond cataract surgery at the Advanced Retinal Therapy meeting.“We are facing a dramatic growth in the demand for cataract surgery due to the aging of the population and to the increasing interest (Read more...)